Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

DXCM – DexCom, Inc.

DexCom, Inc.
DXCM
$79.28
Name : DexCom, Inc.
Sector : Healthcare
Industry: Medical Devices
Mark. Cap: $31,090,049,024.00
EPSttm : 1.42
finviz dynamic chart for DXCM
DexCom, Inc.
$79.28
1.84%
$1.49

Float Short %

2.3

Margin Of Safety %

14

Put/Call OI Ratio

0.92

EPS Next Q Diff

0.22

EPS Last/This Y

0.57

EPS This/Next Y

0.5

Price

79.28

Target Price

103.56

Analyst Recom

1.43

Performance Q

12.84

Relative Volume

1.46

Beta

1.44

Ticker: DXCM




21 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-07-04DXCM82.921.211.36133288
2025-07-07DXCM82.921.220.93131850
2025-07-08DXCM83.761.220.55133402
2025-07-09DXCM84.841.223.24134447
2025-07-10DXCM85.481.281.63139946
2025-07-11DXCM83.381.291.41142584
2025-07-14DXCM85.311.310.81141494
2025-07-15DXCM84.761.300.71143397
2025-07-16DXCM84.151.271.52149178
2025-07-17DXCM84.121.280.72150789
2025-07-18DXCM83.891.213.04156601
2025-07-21DXCM841.040.60134791
2025-07-22DXCM85.131.020.28139349
2025-07-23DXCM86.41.010.21140966
2025-07-24DXCM86.751.000.41141963
2025-07-25DXCM88.980.990.30142611
2025-07-28DXCM89.560.971.89133265
2025-07-29DXCM89.381.050.94141390
2025-07-30DXCM88.331.060.44144884
2025-07-31DXCM80.80.961.73164680
2025-08-01DXCM79.270.920.93165741
DateSymbolLastP/C OIP/C VolTotal OI
21 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-07-04DXCM82.933.146.82.03
2025-07-07DXCM82.913.152.92.03
2025-07-08DXCM83.763.161.02.03
2025-07-09DXCM84.873.163.72.03
2025-07-10DXCM85.463.158.72.03
2025-07-11DXCM83.373.138.82.03
2025-07-14DXCM85.333.172.02.03
2025-07-15DXCM84.783.147.92.03
2025-07-16DXCM84.133.146.92.03
2025-07-17DXCM84.103.152.82.03
2025-07-18DXCM83.893.151.12.03
2025-07-21DXCM84.033.154.42.03
2025-07-22DXCM85.143.163.72.03
2025-07-23DXCM86.433.165.52.03
2025-07-24DXCM86.743.556.02.03
2025-07-25DXCM88.993.574.02.03
2025-07-28DXCM89.543.558.02.03
2025-07-29DXCM89.353.551.52.03
2025-07-30DXCM89.063.550.42.03
2025-07-31DXCM80.773.5-17.02.03
2025-08-01DXCM79.2826.3-15.12.03
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




21 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-07-04DXCM-2.811.442.43
2025-07-07DXCM-2.811.472.43
2025-07-08DXCM-2.811.472.43
2025-07-09DXCM-2.811.472.43
2025-07-10DXCM-2.811.472.43
2025-07-11DXCM-2.811.472.72
2025-07-14DXCM-2.811.952.72
2025-07-15DXCM-2.931.952.72
2025-07-16DXCM-2.931.952.72
2025-07-17DXCM-2.991.952.72
2025-07-18DXCM-2.991.952.72
2025-07-21DXCM-2.992.062.72
2025-07-22DXCM-3.062.062.72
2025-07-23DXCM-3.062.062.72
2025-07-24DXCM-3.062.062.72
2025-07-25DXCM-3.062.062.30
2025-07-28DXCM-3.061.612.30
2025-07-29DXCM-3.081.612.30
2025-07-30DXCM-3.081.612.30
2025-07-31DXCM-2.321.612.30
2025-08-01DXCM-2.321.612.30
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
21 items Current Page1 of 1

Last Quarter Act. EPS

0.48

Avg. EPS Est. Current Quarter

0.57

Avg. EPS Est. Next Quarter

0.7

Insider Transactions

-2.32

Institutional Transactions

1.61

Beta

1.44

Average Sales Estimate Current Quarter

1169

Average Sales Estimate Next Quarter

1279

Fair Value

90.44

Quality Score

90

Growth Score

99

Sentiment Score

16

Actual DrawDown %

51.9

Max Drawdown 5-Year %

-63.3

Target Price

103.56

P/E

55.5

Forward P/E

30.75

PEG

2.3

P/S

7.23

P/B

12.08

P/Free Cash Flow

54.47

EPS

1.43

Average EPS Est. Cur. Y​

2.03

EPS Next Y. (Est.)

2.52

Target Price Estimates Raised

1

Target Price Estimates Lowered

Profit Margin

13.29

Relative Volume

1.46

Return on Equity vs Sector %

-1.5

Return on Equity vs Industry %

4

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

-15.1
DexCom, Inc.
Sector: Healthcare
Industry: Medical Devices
Employees: 10200
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Stelo, a new over-the-counter glucose biosensor designed for adults with prediabetes and Type 2 diabetes. The company has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. It markets its products directly to endocrinologists, physicians, and diabetes educators. The company was incorporated in 1999 and is headquartered in San Diego, California.
stock quote shares DXCM – DexCom, Inc. Stock Price stock today
news today DXCM – DexCom, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch DXCM – DexCom, Inc. yahoo finance google finance
stock history DXCM – DexCom, Inc. invest stock market
stock prices DXCM premarket after hours
ticker DXCM fair value insiders trading